Raltegravir Pharmacokinetics During Pregnancy-Reference-Cited by-同舟云学术

Raltegravir Pharmacokinetics During Pregnancy

Published:2014-12-01 Issue:4 Volume:67 Page:375-381
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Watts D. Heather,Stek Alice,Best Brookie M.,Wang Jiajia,Capparelli Edmund V.,Cressey Tim R.,Aweeka Francesca,Lizak Patty,Kreitchmann Regis,Burchett Sandra K.,Shapiro David E.,Hawkins Elizabeth,Smith Elizabeth,Mirochnick Mark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference12 articles.

1. . Rapid decline in HIV viral load when introducing raltegravir-containing antiretroviral treatment late in pregnancy.;Westling;AIDS Patient Care STDS,2012

2. . Use of newer antiretroviral agents, darunavir and etravirine, with or without raltegravir, in pregnancy: a report of two cases.;Jaworsky;Antivir Ther,2010

3. . High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women.;Mckeown;AIDS,2010

4. . Rapid HIV-RNA decline following addition of raltegraivr and tenofovir to ongoing active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.;Pinetti;J Antimicrob Chemother,2010

5. . Pharmacokinetic and safety of raltegravir in pregnancy.;Croci;Eur J Clin Pharmacol,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Precision Drug Therapy and build pharmacokinetic model in Pregnant Women: PBPK Modeling of Antiviral drugs;2024-07-22

2. Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women;Expert Opinion on Drug Metabolism & Toxicology;2024-05-14

3. Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman Living With Human Immunodeficiency Virus;Clinical Infectious Diseases;2024-05-03

4. Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy;Future Pharmacology;2024-04-10

5. Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy;British Journal of Clinical Pharmacology;2024-02-10